M.A. Argiriadi

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

Julie Parmentier, J W Voss, Candace Graff et al. · BMC Rheumatology · 2018 · 374 citations · Full text

Medicine, Immunology, Pharmacology +16

Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages

Marah C. Runtsch, Stefano Angiari, Alexander Hooftman et al. · Cell Metabolism · 2022 · 318 citations

Life Sciences, Cell Biology, Immunology +14

Detoxification of environmental mutagens and carcinogens: Structure, mechanism, and evolution of liver epoxide hydrolase

M.A. Argiriadi, Christophe Morisseau, Bruce D. Hammock et al. · Proceedings of the National Academy of Sciences · 1999 · 226 citations

Life Sciences, Biochemistry, Molecular Biology +17

Binding of Alkylurea Inhibitors to Epoxide Hydrolase Implicates Active Site Tyrosines in Substrate Activation

M.A. Argiriadi, Christophe Morisseau, Marvin H. Goodrow et al. · Journal of Biological Chemistry · 2000 · 108 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Biochemical Evidence for the Involvement of Tyrosine in Epoxide Activation during the Catalytic Cycle of Epoxide Hydrolase

Takashi Yamada, Christophe Morisseau, Joseph E. Maxwell et al. · Journal of Biological Chemistry · 2000 · 103 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17